Cambridge study identifies astrocyte network as new therapeutic target for Parkinson’s disease	Preview download
Eli Lilly acquires biotech ‘newcomer’ Versanis for $2bn	Preview download
The 10th Central and Western Forum of China Cancer Rehabilitation Organization was held — the national cancer rehabilitation was established at the meeting	Preview download
Digital Pregnancy Rapid Test	Preview download
Digital Ovulation Rapid Test	Preview download
Pregnancy Rapid Test	Preview download
Semi-quantitative Ovulation Rapid Test	Preview download
Ovulation Rapid Test	Preview download
DC908A Multi-Drug Test Cup Reader	Preview download
Marijuana (THC) Saliva Test Midstream	Preview download

Click here to contract to the right

2019-nCoV RBD Antibody Rapid Test

2019-nCoV RBD Antibody Rapid Test is an immunochromatographic assay for rapid, qualitative detection of the novel coronaviruses (2019-nCoV) spike protein receptor-binding domain (RBD) antibodies in human fingerstick whole blood, venipuncture whole blood, serum or plasma specimen.

Details

The Test is used to monitor the presence of 2019-nCoV RBD antibodies in subjects vaccinated with the novel coronavirus vaccine or in people infected with the novel coronavirus.

2019-nCoV RBD Antibody Rapid Test can be used to assess vaccine efficacy after vaccination or whether 2019-nCoV RBD antibodies are produced in human body after infection with novel coronavirus.

For in vitro diagnostic use only.

For professional use only.

STORAGE AND STABILITY

Store at 2°C ~ 30°C in the sealed pouch ,forbidden to store under 2°C.
The test card is used within 15 minutes after taking out from the foil envelope.
Buffer solution are re-capped in time after use.
The buffer should be used immediately after dropping into the dropper.
The kit has a 24 months shelf life from the date of manufacture.